TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 119 resultados LastUpdate Última actualización 23/02/2020 [16:25:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

Página1 de 5 nextPage   por página


COMPOSITE MATRIX FOR ANALYTE BIOSENSORS

NºPublicación: WO2020037269A2 20/02/2020

Solicitante:

UNIV CALIFORNIA [US]

Resumen de: WO2020037269A2

A composite material for detecting and measuring levels of analytes and target molecules in biological fluid and tissue is disclosed herein. This composite material is constructed from a porous mesh sheet that is coated with a signal emitting material and is impregnated with target detecting molecules mixed inside one or multiple polymer mixtures. The geometry and configuration of different constituents can provide high efficiency of signals, the ability to measure multiple signals, small dimensions, fast response to changes, long storage lifetimes, controlled diffusional and mechanical properties, as well as easy industrial manufacturability. The composite material can be used in many sensing applications including optical or electrochemical continuous biosensing such as continuous glucose and lactate monitors.

traducir

Auricular stimulation device

NºPublicación: AU2018309700A1 20/02/2020

Solicitante:

THE FEINSTEIN INSTITUTES FOR MEDICAL RES [US]

WO_2019028000_A1

Resumen de: AU2018309700A1

An auricular stimulation device having surface electrodes biased towards each other, and offset from one another, is provided. The stimulation device can be positioned about the ear of a patient with each of the electrodes overlaying auricular ear tissue containing innervation supplied by an auricular branch of the vagus nerve. The electrodes transcutaneously stimulate the auricular branch. Also provided is a method of treating a patient using the auricular stimulation device. The stimulation device can be used for treating patients with conditions such as high blood pressure, depression, high blood glucose level, and tinnitus. Also provided is a diagnostic and therapeutic system having the auricular stimulation device, a smart device and a monitoring device. The smart device controls the auricular stimulation device based on biomarker information received from the monitoring device; and on information related to the patient, such as age, musculoskeletal stability, etc.; and/or on user input.

traducir

MEDIATED DRUG RELEASE FOR REDUCING IN VIVO ANALYTE INDICATOR DEGRADATION

NºPublicación: US2020054251A1 20/02/2020

Solicitante:

SENSEONICS INCORPORATED [US]

Resumen de: US2020054251A1

A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and one or more boronic acid-drug conjugates configured to release one or more drugs in the presence of a degradative species, wherein the one or more boronic acid-drug conjugates reduce deterioration of the analyte indicator.

traducir

METHODS, SYSTEMS, AND IMPLANTABLE DEVICES FOR ENHANCING BLOOD GLUCOSE REGULATION

NºPublicación: US2020054257A1 20/02/2020

Solicitante:

UNIV ARIZONA [US]

KR_20190104140_A

Resumen de: US2020054257A1

Methods, systems, and devices for regulating blood glucose such as implantable encapsulated devices optionally with insulin and/or giucacon secreting cells in combination with glucose sensors and insulin infusion systems. For example, encapsulation devices may be connected to an insulin infusion pump for distribution of insulin. The insulin infusion pump may feature an insulin pouch fluidly connected to an insulin pump (or a syringe) and a glucose sensor separate from the encapsulation device. The system may feature an additional implantable device comprising insulin and glucagon secreting cells.

traducir

SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA

NºPublicación: US2020057075A1 20/02/2020

Solicitante:

UNIV CALIFORNIA [US]

KR_20190117555_A

Resumen de: US2020057075A1

A method for detection or monitoring status of silent brain ischemia (SBI) and cerebrovascular health. The assay reagents and methods described herein provide a specific indicator of cerebral microvascular disease, enabling clinicians to identify patients at risk for the development of SBI. A method of treating a subject having silent brain ischemia and/or metabolic syndrome comprises administering to the subject aspirin therapy, blood pressure therapy, body weight management, and/or a program of diet and exercise when levels of two or more SBI markers are elevated. Described herein are molecules that are produced by cerebral endothelial cells exposed to chronic vascular risk factors including obesity, hyperlipidemia, hypertension, and glucose intolerance. These stress molecules produced by cerebral endothelial cells are detectable in the serum and serve as diagnostic indicators of brain-specific endothelial cell damage and correlate with MRI indicators of silent stroke and impaired cognitive function.

traducir

ADAPTIVE ARTIFICIAL INTELLEGENCE INSULIN PUMP

NºPublicación: US2020058386A1 20/02/2020

Solicitante:

KELLY SAMATHA GRACE [US]

Resumen de: US2020058386A1

An artificial intelligence insulin pump that processes glucose data, wellness data, external data, and port information to determine the appropriate amount and timing of insulin to deliver to a person. External data includes data from sources remote from the insulin pump and the user such as social media data, GPS location data, historical data including energy and food intake at locations visited prior, data from third party sources. Such external data may include that the use is registered for a marathon and in at the marathon venue and the user's exertion level indicates that the user is running has begun to run the marathon. The AI engine would than adjust the insulin appropriately.

traducir

SENSOR CALIBRATION

NºPublicación: US2020054254A1 20/02/2020

Solicitante:

BAXTER INT [US]
BAXTER HEALTHCARE SA [CH]

JP_2017506940_A

Resumen de: US2020054254A1

A process for calibrating a glucose sensor under sterile conditions includes providing separate, sterile, glucose-containing calibration fluids, each having a different glucose concentration, and in turn providing these fluids to a sensing zone containing a sensing probe of a glucose sensor. Each solution is typically, in turn, propelled into the sensing zone, thus flushing out used fluid already present in the sensing zone. The process provides rapid calibration of a glucose sensor in a sterile fashion and is therefore appropriate for point-of-use calibration.

traducir

ANALYTE SENSOR

NºPublicación: US2020046272A1 13/02/2020

Solicitante:

DEXCOM INC [US]

US_2014213869_A1

Resumen de: US2020046272A1

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into a host's peripheral vein or artery.

traducir

OPTICAL GLUCOMETER

NºPublicación: US2020046274A1 13/02/2020

Solicitante:

FURMAN UNIV [US]

US_2019336052_A1

Resumen de: US2020046274A1

Disclosed herein are devices and methods for detecting blood glucose levels in a subject that involve passively quantifying mid-infrared emissions from the eye of the subject.

traducir

SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR A BASAL RATE PROFILE ADAPTATION ALGORITHM FOR CLOSED-LOOP ARTIFICIAL PANCREAS SYSTEMS

NºPublicación: US2020046268A1 13/02/2020

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

WO_2018152358_PA

Resumen de: US2020046268A1

An insulin device configured to control insulin dosage adapts a basal rate profile, using a sensor configured to produce a blood glucose level measurement data, and detect changes of the blood glucose level measurement data over time. A processor is configured to receive the blood glucose level measurement data and a basal rate profile. A basal rate set point corresponds to an insulin delivery reference for a nominal blood glucose. The insulin device includes an insulin dispensing valve controlled by the processor to administer insulin in accordance with the received basal rate profile. The processor is configured to update the basal rate set point over a time period based on both an assessment of at least one of a risk of hyperglycemia and a risk of hypoglycemia from historical blood glucose data, and patterns of actions taken by the insulin device to mitigate glycemic risk during the time period.

traducir

DIABETES THERAPY TRAINING DEVICE

NºPublicación: US2020051454A1 13/02/2020

Solicitante:

BECTON DICKINSON CO [US]

CN_110520934_A

Resumen de: US2020051454A1

A portable device (20) for educating a user in diabetes management includes a display (26) presenting a user interface to provide a virtual patient (28) having diabetes and depicted as an avatar having the form of a boy or girl. A health status (30) is indicated by a bar graph (32). The user interface presents a feeding control (40) for providing food or drinks to the virtual patient; an exercise control (38) for causing the virtual patent to exercise; and a medication control for providing medication to the virtual patient. Each of the controls causing a corresponding change in the health status of the virtual patient having type-1 diabetes. An injection training application (34) is provided for teaching injection techniques. A testing training application (36) allows the user to check one or more health parameters of the virtual patient. Other applications, such as exercise and diet logging applications and an activities checklist are included as well.

traducir

Handheld Diabetes Management Device With Bolus Calculator

NºPublicación: US2020049691A1 13/02/2020

Solicitante:

ROCHE DIABETES CARE INC [US]

US_2014058237_PA

Resumen de: US2020049691A1

According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.

traducir

METHOD FOR NON-INVASIVE BLOOD GLUCOSE MONITORING

NºPublicación: WO2020029898A1 13/02/2020

Solicitante:

FOSHAN HL SCIENCE & TECH LIMITED [CN]

Resumen de: WO2020029898A1

An approach to improve the accuracy of non-invasive infrared based glucose measurements, making use of a simultaneous pressure reading at the infrared measurement location, which is used to determine a more accurate non-invasive blood glucose estimate.

traducir

DOCTOR HEALTH MONITORING SYSTEM BASED ON MEDICAL APPARATUS

NºPublicación: WO2020029814A1 13/02/2020

Solicitante:

WUHAN YOUCARE TECH CO LTD [CN]

CN_109009024_A

Resumen de: WO2020029814A1

A doctor health monitoring system based on a medical apparatus (1). The system comprises the medical apparatus (1), a detecting system (2), a control system (3) and an artificial intelligence system (14). The detecting system (2) is used for detecting health indices of a doctor and transmitting detected data to the control system (3). The control system (3) and the artificial intelligence system (14) are integrated into the medical apparatus (1), and the control system (3) is used for transmitting received data to a display device (11) for display. The artificial intelligence system (14) is used for carrying out analysis and research according to data in a cloud server (12), so as to acquire diagnosis accuracy of the health indices and predict the health condition of the doctor. In the present system, the detecting system (2) capable of detecting the health indices of a doctor is connected to the medical apparatus (1), so that the health indices of the doctor may be detected in real time, the body health condition of the doctor may be learned, and conditions such as the doctor having low blood sugar during a diagnosis process may be resolved in time, thereby ensuring a smooth treatment process.

traducir

MEDICAL SENSOR SYSTEM, IN PARTICULAR CONTINUOUS GLUCOSE MONITORING SYSTEM

NºPublicación: US2020046270A1 13/02/2020

Solicitante:

ROCHE DIABETES CARE INC [US]

CN_110446464_A

Resumen de: US2020046270A1

This disclosure concerns a medical sensor system comprising a sensor implantable under the skin of a user and an on-body module attachable to the skin in the region of the implantable sensor, wherein the on-body module has a self-adhering flexible electronics patch including a first transmitter which is operable to exchange data with the implantable sensor via a short-range wireless connection.

traducir

APPARATUS FOR CONTROLLING OPERATION OF CONTINUOUS BLOOD GLUCOSE TESTER

NºPublicación: WO2020032382A1 13/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020032382A1

The present invention relates to an apparatus for controlling the operation of a continuous blood glucose tester and, more particularly, to an apparatus for controlling the operation of a continuous blood glucose tester, the apparatus supplying battery power to the continuous blood glucose tester through a power switch, which is turned on by an enable signal generated by a near field communication module when the apparatus is located within a predetermined distance from a user terminal, so as to start the operation of the continuous blood glucose tester without the separate intervention of a user, providing connection information from the near field communication module to the user terminal so as to automatically perform a pairing connection with the user terminal through the near field communication module and a Bluetooth communication module, and providing an enable signal generated by the Bluetooth communication module to the power switch when the pairing connection with the user terminal is completed, so as to maintain the pairing connection with the user terminal even when the user terminal is out of the near field communication distance.

traducir

BLOOD GLUCOSE MANAGEMENT SYSTEM

NºPublicación: EP3607876A1 12/02/2020

Solicitante:

ROCHE DIABETES CARE GMBH [DE]
HOFFMANN LA ROCHE [CH]

US_2010331651_PA

Resumen de: EP3607876A1

A blood glucose management device is operable to seamlessly provide a sequence of at least two displays of data relating to one or more blood glucose measurements to a user, upon minimal user interaction, with the blood glucose management device.

traducir

INSULIN-ON-BOARD ACCOUNTING IN AN ARTIFICIAL PANCREAS SYSTEM

NºPublicación: EP3606584A1 12/02/2020

Solicitante:

LIFESCAN IP HOLDINGS LLC [US]

KR_20190132684_A

Resumen de: US2018289891A1

An artificial pancreas system includes a continuous glucose monitoring device, a drug delivery device configured to exchange data with the continuous glucose monitoring device and containing a control algorithm, and possibly a remote controller configured to exchange data with the drug delivery device. The algorithm contains an insulin-glucose model, but is decoupled mathematically from the insulin injected by the user to offset the ingested carbohydrates. The control algorithm is designed to calculate two versions of insulin-on-board-patient-facing insulin-on-board (PFIOB) and system-facing insulin-on-board (SFIOB) to properly parse boluses and inform the system of only the insulin that is intended for high glucose correction, but not carbohydrate offsetting.

traducir

CONTINUOUS BLOOD SUGAR MEASURING DEVICE

NºPublicación: WO2020027423A1 06/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020027423A1

The present invention relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.

traducir

BODY ATTACHMENT UNIT FOR CONTINUOUS BLOOD GLUCOSE MONITORING

NºPublicación: WO2020027425A1 06/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020027425A1

The present invention relates to a body attachment unit for continuous blood glucose monitoring, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and activation occurs in a stabilized state, thereby allowing more accurate blood glucose monitoring.

traducir

BODY ATTACHMENT UNIT FOR CONTINUOUS BLOOD GLUCOSE MONITORING

NºPublicación: WO2020027434A1 06/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020027434A1

The present invention relates to a body attachment unit for continuous blood glucose monitoring, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and activation can occur in a stabilized state, and thereby allowing more accurate blood glucose monitoring.

traducir

CONTINUOUS GLUCOSE MONITORING DEVICE

NºPublicación: WO2020027424A1 06/02/2020

Solicitante:

I SENS INC [KR]

Resumen de: WO2020027424A1

The present invention relates to a continuous glucose monitoring device. The present invention provides a continuous glucose monitoring device wherein: a body attachment unit is manufactured in the state in which the body attachment unit is assembled in an applicator, and thus a user's additional work for attaching the body attachment unit to the body is minimized and the body attachment unit can be attached to the body by simply operating the applicator; in particular, a wireless communication chip is disposed in the body attachment unit so as to communicate with an external terminal, and thus simple and convenient use can be achieved without any additional work for connection of a separate transmitter and maintenance and management can also be easily performed; and the monitoring operation is started by the user's manipulation after the body attachment unit is attached to the body, and thus the user can adjust the operation start time to an appropriate point as necessary and the operation can be started in a stabilized state so as to enable more accurate glucose monitoring.

traducir

SYSTEM FOR DETECTING EATING WITH SENSOR MOUNTED BY THE EAR

NºPublicación: WO2020028481A1 06/02/2020

Solicitante:

DARTMOUTH COLLEGE [US]
UNIV CLEMSON [US]

Resumen de: WO2020028481A1

A wearable device for detecting eating episodes uses a contact microphone to provide audio signals through an analog front end to an analog-to-digital converter to digitize the audio and provide digitized audio to a processor; and a processor configured with firmware in a memory to extract features from the digitized audio. A classifier determines eating episodes from the extracted features. In embodiments, messages describing the detected eating episodes are transmitted to a cell phone, insulin pump, or camera configured to record video of the wearer's mouth.

traducir

Diabetes management partner interface for wireless communication of analyte data

NºPublicación: AU2018362257A1 06/02/2020

Solicitante:

DEXCOM INC

US_2019173885_A1

Resumen de: AU2018362257A1

Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.

traducir

RECEIVERS FOR ANALYZING AND DISPLAYING SENSOR DATA

Nº publicación: US2020037965A1 06/02/2020

Solicitante:

DEXCOM INC [US]

US_2019192087_A1

Resumen de: US2020037965A1

This disclosure provides systems, methods and apparatus for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor. The system may include a display device with at least one input device. In response to movement of or along the input device, the display device may change a glucose data output parameter and update an output of the display device using the changed output parameter.

traducir

Página1 de 5 nextPage por página

punteroimgVolver